CTEV Claritev Corp.
Price (delayed)
$20.49
Market cap
$331.9M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$101.92
Enterprise value
$4.84B
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based
Highlights
The equity has plunged by 95% YoY and by 60% from the previous quarter
CTEV's quick ratio is down by 34% YoY and by 31% QoQ
Key stats
What are the main financial stats of CTEV
Market
Valuations
Earnings
Shares outstanding
16.2M
Market cap
$331.9M
Enterprise value
$4.84B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.94
Price to sales (P/S)
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.2
Revenue
$930.62M
Gross profit
$691.22M
Operating income
-$1.39B
Net income
-$1.65B
EBIT
-$1.44B
EBITDA
-$1.01B
Free cash flow
-$10.51M
Per share
Balance sheet
Liquidity
EPS
-$101.92
EPS diluted
-$101.92
Free cash flow per share
-$0.65
Book value per share
$5.2
Revenue per share
$57.63
TBVPS
$32.29
Total assets
$5.15B
Total liabilities
$5.07B
Debt
$4.54B
Equity
$84.02M
Working capital
-$38.28M
Debt to equity
54.05
Current ratio
0.82
Quick ratio
0.66
Net debt/EBITDA
-4.48
Margins
Efficiency
Dividend
EBITDA margin
-108.3%
Gross margin
74.3%
Net margin
-176.9%
Operating margin
-149.4%
Return on assets
-29.2%
Return on equity
-318.8%
Return on invested capital
-30%
Return on capital employed
-29.3%
Return on sales
-155.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CTEV stock price
How has the Claritev stock price performed over time
Intraday
-1.01%
1 week
-6.69%
1 month
-2.38%
1 year
-36.47%
YTD
38.63%
QTD
-0.68%
Financial performance
How have Claritev's revenue and profit performed over time
Revenue
$930.62M
Gross profit
$691.22M
Operating income
-$1.39B
Net income
-$1.65B
Gross margin
74.3%
Net margin
-176.9%
CTEV's operating margin is down by 8% QoQ
Claritev's net margin has decreased by 8% from the previous quarter
CTEV's net income is down by 7% since the previous quarter
The operating income has declined by 6% since the previous quarter
Growth
What is Claritev's growth rate over time
Valuation
What is Claritev stock price valuation
P/E
N/A
P/B
3.94
P/S
0.36
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.2
Claritev's EPS has decreased by 7% QoQ
The equity has plunged by 95% YoY and by 60% from the previous quarter
The stock's price to book (P/B) is 87% less than its 5-year quarterly average of 31.5
The stock's price to sales (P/S) is 84% less than its 5-year quarterly average of 2.2 but 20% more than its last 4 quarters average of 0.3
CTEV's revenue is down by 3.2% year-on-year
Efficiency
How efficient is Claritev business performance
The ROE has plunged by 91% from the previous quarter
The return on assets has declined by 16% since the previous quarter
Claritev's return on sales has decreased by 14% QoQ
The ROIC has contracted by 12% from the previous quarter
Dividends
What is CTEV's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CTEV.
Financial health
How did Claritev financials performed over time
CTEV's quick ratio is down by 34% YoY and by 31% QoQ
The current ratio has contracted by 29% YoY and by 22% from the previous quarter
The company's debt to equity has surged by 147% QoQ
The equity has plunged by 95% YoY and by 60% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.